Treatment strategy for cutaneous malignant melanoma

International Journal of Clinical Oncology

Volumn 10, Issue 5, 2005, Pages 311-317

  Tsutsumida, Arata ^a   Furukawa, Hiroshi ^a   Yamamoto, Yuhei ^a   Sugihara, Tsuneki ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cutaneous melanoma; Surgery; Treatment

Indexed keywords

CARMUSTINE; CISPLATIN; DACARBAZINE; NIMUSTINE; PLATINUM DERIVATIVE; RECOMBINANT BETA INTERFERON; TAMOXIFEN; TAXANE DERIVATIVE; VINCRISTINE;

CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; ESTHETIC SURGERY; HUMAN; JAPAN; MELANOMA; PATIENT SATISFACTION; PRIORITY JOURNAL; REVIEW; SENTINEL LYMPH NODE BIOPSY; SKIN CARCINOMA; SURGICAL TECHNIQUE;

HUMANS; LYMPHATIC METASTASIS; MELANOMA; SKIN NEOPLASMS;

EID: 27144511725     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-005-0522-9     Document Type: Review

References (72)

1. K Ishihara A Saida A Yamamoto 2004 Nationwide survey of malignant skin tumors (1997-2001) Skin Cancer 19 147 155
2. R Essner 2003 Surgical treatment of malignant melanoma Surg Clin North Am 83 109 156
3. AE Chang TM Johnson R Rees 1997 Cutaneous neoplasms Surgery: scientific principles and practice 3rd edn. Lippincott-Raven Philadelphia 2231 2246
4. WS Handley 1907 The pathology of melanotic growths in relation to their operative treatment Lancet I 927 933
5. CK Wong 1970 A study of melanocytes in the normal skin surrounding malignant melanomata Dermatologica 141 215 225
6. JW Kelly RW Sagebiel W Calderon 1984 The frequency of local recurrence and microsatellites as a guide to re-excision margins for cutaneous malignant melanoma Ann Surg 20 759 763
7. U Veronesi N Cascinelli J Adamus 1988 Thin stage I primary cutaneous malignant melanoma: comparison of excision with margins of 1 or 3∈cm N Engl J Med 322 1159 1162
8. M Santinami A Maurichi R Patuzzo 2001 Impact of clinical trials on the treatment of melanoma Surg Oncol Clin North Am 10 935 947
9. CM Balch MM Urist CC Karakousis 1993 Efficacy of 2-cm surgical margins for intermediate thickness melanomas (1 to 4∈mm): results of a multi-institutional randomized surgical trial Ann Surg 218 262 267
10. CM Balch SJ Soong T Smith 2001 Long-term results of a prospective surgical trial comparing 2-cm vs 4-cm excision margins for 740 patients with 1-4∈mm melanomas Ann Surg Oncol 8 101 108
11. G Cohn-Cedermark LE Rutqvist R Andersson 2000 Long term results of a randomized study by the Swedish Melanoma Group on 2-cm vs 5-cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8-2.0∈mm Cancer 89 1495 1501
12. KM Heaton JJ Sussman JE Gershenwald 1998 Surgical margins and prognostic factors in patients with thick (>4∈mm) primary melanoma Ann Surg Oncol 5 322 328
13. T Saida M Takikawa A Yamamoto 2002 General rules for clinical and pathological studies on malignant neoplasms of the skin Kanehara Tokyo 16 37
14. DL Morton DS Hoon AJ Cochran 2003 Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma Ann Surg 238 528 550
15. F de Braud D Khayat BB Kroon 2003 Malignant melanoma Crit Rev Oncol Hematol 47 35 63
16. CP Karakousis DL Driscoll B Rose 1994 Groin dissection in malignant melanoma Ann Surg Oncol 1 271 277
17. CM Balch N Cascinelli GW Milton 1985 Elective node dissection: pros and cons Cutaneous melanoma: clinical management and treatment results worldwide 3rd edn. Lippincott Philadelphia 131
18. T Sugihara T Yoshida I Kokubu 1994 Prognostic evaluation of cutaneous malignant melanoma based on the pTNM classification J Dermatol 21 953 959
19. T Sugihara T Yoshida T Ohura 1991 Clinical evaluation of cutaneous malignant melanoma with histologically involved lymph node metastases J Dermatol 18 592 597
20. CM Balch 1988 The role of elective lymph node dissection in melanoma: rationale, results and controversies J Clin Oncol 6 163 172
21. U Veronesi J Adams DC Bandiera 1982 Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities Cancer 49 2420 2430
22. CM Balch S Soong MI Ross 2000 Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0∈mm) Ann Surg Oncol 7 87 97
23. DL Morton DR Wen JH Wong 1992 Technical details of intraoperative lymphatic mapping for early stage melanoma Arch Surg 127 392 399
24. MS Sabel JF Gibbs R Cheney 2000 Evolution of sentinel lymph node biopsy for melanoma at a National Cancer Institute-designated cancer center Surgery 128 556 563
25. JF Thompson WH McCarthy CM Bosch 1995 Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes Melanoma Res 5 255 260
26. JE Gershenwald MI Colome JE Lee 1998 Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma J Clin Oncol 16 2253 2260
27. AJ Cochran BR Balda H Starz 2000 The Augsburg Consensus. Techniques of lymphatic mapping, sentinel lymphadenectomy, and completion lymphadenectomy in cutaneous malignancies Cancer 89 236 241
28. JE Gershenwald W Thompson PE Mansfield 1999 Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients J Clin Oncol 17 976 983
29. N Cascinelli F Belli M Santinami 2000 Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience Ann Surg Oncol 7 469 474
30. RJ Bleicher R Essner LJ Foshag 2003 Role of sentinel lymphadenectomy in thin invasive cutaneous melanomas J Clin Oncol 21 1326 1331
31. JD Wagner MS Gordon TY Chuang 2000 Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma Cancer 89 453 462
32. JD Wagner D Davidson JJ Coleman 1999 Lymph node tumor volumes in patients undergoing sentinel lymph node biopsy for cutaneous melanoma Ann Surg Oncol 6 398 404
33. R Essner A Conforti MC Kelley 1999 Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma Ann Surg Oncol 6 442 449
34. KM McMasters SL Wong MJ Edwards 2002 Frequency of nonsentinel lymph node metastasis in melanoma Ann Surg Oncol 9 137 141
35. E Joseph A Brobeil F Glass 1998 Results of complete lymph node dissection in 83 melanoma patients with positive sentinel nodes Ann Surg Oncol 5 119 125
36. ME Reeves R Delgado KJ Busam 2003 Prediction of nonsentinel lymph node status in melanoma Ann Surg Oncol 10 27 31
37. JH Lee R Essner H Torisu-Itakura 2004 Factors predictive of tumor-positive nonsentinel lymph nodes after tumor-positive sentinel lymph node dissection for melanoma J Clin Oncol 22 3677 3684
38. AJ Cochran DR Wen RR Huang 2004 Prediction of metastatic melanoma in non-sentinel nodes and clinical outcome based on the primary melanoma and the sentinel node Mod Pathol 17 747 755
39. H Starz BR Balda KU Kramer 2001 Micromorphometric-based concept for routine classification of sentinel lymph node metastasis and its clinical relevance for patients with melanoma Cancer 91 2110 2121
40. RA Scolyer LX Li SW McCarthy 2004 Micromorphometric features of positive sentinel lymph nodes predict involvement of nonsentinel nodes in patients with melanoma Am J Clin Pathol 122 532 539
41. MT Ballo AK Kian 2003 Radiation therapy for malignant melanoma Surg Clin N Am 83 323 342
42. EA Strom MI Ross 1995 Adjuvant radiation therapy after axillary lymphadenectomy for metastatic melanoma: toxicity and local control Ann Surg Oncol 2 445 449
43. MT Ballo MD Bonnen AS Garden 2003 Adjuvant irradiation for cervical lymph node metastases from melanoma Cancer 97 1789 1796
44. ES Chung MS Sabel VK Sondak 2004 Current state of treatment for primary cutaneous melanoma Clin Exp Med 4 65 77
45. RS Bart NR Porzio AW Kopf 1980 Inhibition of growth of B16 murine malignant melanoma by exogenous interferon Cancer Res 40 614 619
46. MB Lens M Dawes 2002 Interferon alfa therapy for malignant melanoma: a systematic review of randomized controlled trials J Clin Oncol 20 1818 1825
47. A Yamamoto K Ishihara 1996 Clinical Study of DAV-IFNS61538 therapy for malignant melanoma Int J Immunother 12 73 78
48. WH McCarthy HM Shaw JF Thompson 1988 Time and frequency of recurrence of cutaneous stage I malignant melanoma with guidelines for follow-up study Surg Gynecol Obstet 166 497 502
49. H Tsao AB Cosimi AJ Sober 1997 Ultra-late recurrence (15 years or longer) of cutaneous melanoma Cancer 79 2361 2370
50. CP Karakousis AA Bartolucci CM Balch 1998 Local recurrence and its management CM Balch AN Houghton AJ Sober SJ Soong Cutaneous melanoma 3rd edn Quality Medical Publishing St. Louis 155 162
51. P Leon JM Daly M Synnestvedt 1991 The prognostic implications of microscopic satellites in patients with clinical stage I melanoma Arch Surg 126 1461 1468
52. CP Karakousis CM Balch MM Urist 1996 Local recurrence in malignant melanoma: long-term results of the multiinstitutional randomized surgical trial Ann Surg Oncol 3 446 452
53. DG Coit 1998 Patient surveillance and follow-up CM Balch AN Houghton AJ Sober SJ Soong Cutaneous melanoma 3rd edn. Quality Medical Publishing St. Louis 313 323
54. DL Fraker 1998 Hyperthermic regional perfusion for melanoma of the limbs CM Balch AN Houghton AJ Sober SJ Soong Cutaneous melanoma 3rd edn. Quality Medical Publishing St. Louis 281 300
55. AK Kian 1998 Radiotherapy for melanoma SJ Soon Cutaneous melanoma 3rd edn. Quality Medical Publishing St. Louis 389 403
56. WT Sauze 1991 Fraction size in extenal beam radiation therapy in the treatment of melanoma Int J Radiat Oncol Biol Phys 20 419 432
57. DG Coit 1998 Recurrent regional metastases and their management CM Balch AN Houghton AJ Sober SJ Soong Cutaneous melanoma 3rd edn. Quality Medical Publishing St. Louis 301 309
58. J Nakayama M Takeuchi H Mayumi 1996 Two cases of metastatic malignant melanoma of the lower limb treated with hyperthermic isolated limb perfusion and concomitant infusion of either carboplatin or beta-interferon J Dermatol 23 6 15
59. DL Fraker HR Alexander D Bartlett 1996 A prospective randomized trial of therapeutic isolated limb perfusion (ILP) comparing melphalan (M), tumor necrosis factor (TNF) and interferon gamma (INF[gamma]): an initial report (abstract Prog Proc Soc Surg Oncol 29 6
60. CM Anderson AC Buzaid SS Legha 1995 Systemic treatments for advanced cutaneous melanoma Oncology 9 1149 1158
61. A Tsutsumida Y Yamamoto T Sugihara 2004 Analysis of melanoma patients with distant metastases J Jpn Plast Reconstr Surg 24 483 486
62. ML Myers CM Balch 1998 Diagnosis and treatment of metastatic melanoma CM Balch AN Houghton AJ Sober SJ Soong Cutaneous melanoma 3rd edn. Quality Medical Publishing St. Louis 325 372
63. AC Berger JF Buell D Venzon 1999 Management of symptomatic malignant melanoma of the gastrointestinal tract Ann Surg Oncol 6 155 160
64. JD Wagner MS Gordon TY Chuang 2000 Current therapy of cutaneous melanoma Plast Reconstr Surg 105 1774 1799
65. AC Buzaid A Bedikian AN Houghton 1998 Systemic chemotherapy and biochemotherapy CM Balch AN Houghton AJ Sober SJ Soong Cutaneous melanoma 3rd edn. Quality Medical Publishing St. Louis 405 418
66. SB Saxman ML Meyers PB Chapman 1999 A phase III multicenter randomized trial of DTIC, cisplatin, BCNU and tamoxifen versus DTIC alone in patients with metastatic melanoma (abstract) Proc Am Soc Clin Oncol 18 536
67. SA Del Prete LH Maurer J O'Donnell 1984 Combination chemotherapy with cisplatin, carmustine, dacarbazine, and tamoxifen in metastatic melanoma Cancer Treat Rep 68 1403 1405
68. N Yamazaki A Yamamoto T Wada 1999 Dacarbazine, nimustine hydrochloride, cisplatin and tamoxifen combination chemotherapy for advanced malignant melanoma J Dermatol 26 489 493
69. H Iwata N Yamazaki Y Yamamoto 2005 Dacarbazine, nimustine, cisplatin and tamoxifen combination chemotherapy (DAC-Tam regimen) for metastatic melanoma Jpn J Dermatol 115 879 885
70. KK Ang FB Geara RM Byers 1998 Radiotherapy for melanoma CM Balch AN Houghton AJ Sober SJ Soong Cutaneous melanoma 3rd edn. Quality Medical Publishing St. Louis 389 403
71. S Somaza D Kondziolka LD Lunsford 1993 Stereotactic radiosurgery for cerebral metastatic melanoma J Neurosurg 79 661 666
72. Y Akiyama R Tanosaki N Inoue 2005 Clinical response in Japanese metastatic melanoma patients treated with peptide cocktail-pulsed dendritic cells J Transl Med 28 4